INVOKANA 100 mg/1
canagliflozin · TABLET, FILM COATED · Janssen Pharmaceuticals, Inc.
Invokana (canagliflozin) is an oral tablet used to help lower blood sugar levels in people with type 2 diabetes. It belongs to a class of diabetes medications that work by helping your kidneys remove excess sugar through urine.
Key Facts
- Brand Name
- INVOKANA
- Generic Name
- canagliflozin
- NDC Code (Product)
50458-140- Manufacturer
- Janssen Pharmaceuticals, Inc.
- Strength
- 100 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA204042
- Marketing Start
- 03/29/2013
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is INVOKANA used for?
Invokana (canagliflozin) is an oral tablet used to help lower blood sugar levels in people with type 2 diabetes. It belongs to a class of diabetes medications that work by helping your kidneys remove excess sugar through urine.
Is INVOKANA a controlled substance?
INVOKANA is not classified as a controlled substance by the DEA.
What is the generic name for INVOKANA?
The generic name for INVOKANA is canagliflozin. There are 7 other brand versions of canagliflozin.
What is the NDC code for INVOKANA 100 mg/1?
The NDC (National Drug Code) for INVOKANA 100 mg/1 is 50458-140, listed by Janssen Pharmaceuticals, Inc..